Aegle Therapeutics Corp

CIK 1797825 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Aegle Therapeutics Corp.

Recent SEC filings

FiledFormAccession number
Aug 28, 2026D0001797825-26-000007
Mar 3, 2026D0001231919-26-000232
Jul 28, 2020D/A0001797825-20-000003
May 14, 2020D/A0001797825-20-000002
Jan 7, 2020D0001797825-20-000001